Abstract
Patients with antiphospholipid syndrome can suffer recurrent thrombosis that is very difficult to manage. Recent research has demonstrated that high-intensity anticoagulation is not superior to standard therapy. Basic questions about the nature and treatment of this syndrome remain unanswered.
MeSH terms
-
Adult
-
Anticoagulants / therapeutic use
-
Antiphospholipid Syndrome / complications
-
Antiphospholipid Syndrome / diagnosis*
-
Antiphospholipid Syndrome / drug therapy*
-
Female
-
Humans
-
Middle Aged
-
Risk Factors
-
Secondary Prevention
-
Thrombosis / etiology
-
Thrombosis / prevention & control*
-
Warfarin / therapeutic use*